Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Mymd Pharmaceuticals Inc MYMD

Healthcare
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MYMD)

MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Business Wire March 5, 2024

MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

Business Wire February 13, 2024

MyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment Drug

Accesswire December 29, 2023

MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis

Business Wire December 6, 2023

MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD(TM), Reduced Acute Inflammatory Pain

Business Wire October 19, 2023

MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023

Business Wire October 4, 2023

FDA Accepts MyMD Pharmaceuticals' Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA)

Business Wire August 14, 2023

MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results

Business Wire August 2, 2023

MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF-α Inhibitor MYMD-1® in Sarcopenia/Age-Related Frailty

Business Wire July 31, 2023
View More News ››

Opinion & Analysis (NDAQ:MYMD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:MYMD)

C'mon share price

GripnRip - 9 days ago

How the Dickens do you trade 8M shares

When only 2M shares outstanding? Wash trades?
GripnRip - 9 days ago

No current FDA approved treatment for sarcopenia, MYMD could

...own the only FDA approved treatment plus a pipeline for other treatments In a recently completed phase 2 clinical trial, MYMD-1...
Ogopogo007 - December 29, 2023

up 40% today

that won't help my stockpickingcontest pick...lol
Ogopogo007 - December 27, 2023

SP keeps climbing slowly

Trend is up but day-to-day jigsaw action
Ogopogo007 - May 26, 2023

No love as yet from Merek buying RXDX for $10.8B

certainly some heavyweight action going on in this sector, c'on MYMD....$1B buyout would almost be a 20 bagger Migh have to buy some...
Ogopogo007 - April 18, 2023
View more Bullboard ››

Fokus Mining Corp

Fokus Mining Corp

Fokus Mining Corporation is a Canada-based mineral resource company. The Company is engaged in acquiring, exploring and ...
View More »